-
Something wrong with this record ?
Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders
T. Hajek, C. Calkin, R. Blagdon, C. Slaney, R. Uher, M. Alda,
Language English Country England, Great Britain
Document type Journal Article, Research Support, Non-U.S. Gov't
NLK
Free Medical Journals
from 1994 to 1 year ago
PubMed Central
from 2010 to 1 year ago
Europe PubMed Central
from 2010 to 1 year ago
ProQuest Central
from 2000-01-01 to 2017-12-31
Open Access Digital Library
from 1994-01-01
Medline Complete (EBSCOhost)
from 2004-06-01 to 2015-12-02
Health & Medicine (ProQuest)
from 2000-01-01 to 2017-12-31
Psychology Database (ProQuest)
from 2000-01-01 to 2017-12-31
PubMed
25074491
DOI
10.1038/npp.2014.148
Knihovny.cz E-resources
- MeSH
- Bipolar Disorder complications metabolism pathology MeSH
- Diabetes Mellitus, Type 2 complications pathology MeSH
- Adult MeSH
- Insulin Resistance * MeSH
- Middle Aged MeSH
- Humans MeSH
- Magnetic Resonance Imaging MeSH
- Brain pathology MeSH
- Image Processing, Computer-Assisted MeSH
- Glucose Intolerance MeSH
- Cross-Sectional Studies MeSH
- Aging pathology MeSH
- Organ Size MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Type 2 diabetes mellitus (T2DM) damages the brain, especially the hippocampus, and frequently co-occurs with bipolar disorders (BD). Reduced hippocampal volumes are found only in some studies of BD subjects and may thus be secondary to the presence of certain clinical variables. Studying BD patients with abnormal glucose metabolism could help identify preventable risk factors for hippocampal atrophy in BD. We compared brain structure using optimized voxel-based morphometry of 1.5T MRI scans in 33 BD subjects with impaired glucose metabolism (19 with insulin resistance/glucose intolerance (IR/GI), 14 with T2DM), 15 euglycemic BD participants and 11 euglycemic, nonpsychiatric controls. The group of BD patients with IR, GI or T2DM had significantly smaller hippocampal volumes than the euglycemic BD participants (corrected p=0.02) or euglycemic, nonpsychiatric controls (corrected p=0.004). Already the BD subjects with IR/GI had smaller hippocampal volumes than euglycemic BD participants (t(32)=-3.15, p=0.004). Age was significantly more negatively associated with hippocampal volumes in BD subjects with IR/GI/T2DM than in the euglycemic BD participants (F(2, 44)=9.96, p=0.0003). The gray matter reductions in dysglycemic subjects extended to the cerebral cortex, including the insula. In conclusion, this is the first study demonstrating that T2DM or even prediabetes may be risk factors for smaller hippocampal and cortical volumes in BD. Abnormal glucose metabolism may accelerate the age-related decline in hippocampal volumes in BD. These findings raise the possibility that improving diabetes care among BD subjects and intervening already at the level of prediabetes could slow brain aging in BD.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15031934
- 003
- CZ-PrNML
- 005
- 20151014102425.0
- 007
- ta
- 008
- 151005s2014 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/npp.2014.148 $2 doi
- 035 __
- $a (PubMed)25074491
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Hajek, Tomas $u 1] Department of Psychiatry, Dalhousie University, Halifax, NS, Canada [2] Prague Psychiatric Center, Department of Psychiatry and Medical Psychology, 3rd School of Medicine, Charles University, Prague, Czech Republic.
- 245 10
- $a Insulin resistance, diabetes mellitus, and brain structure in bipolar disorders / $c T. Hajek, C. Calkin, R. Blagdon, C. Slaney, R. Uher, M. Alda,
- 520 9_
- $a Type 2 diabetes mellitus (T2DM) damages the brain, especially the hippocampus, and frequently co-occurs with bipolar disorders (BD). Reduced hippocampal volumes are found only in some studies of BD subjects and may thus be secondary to the presence of certain clinical variables. Studying BD patients with abnormal glucose metabolism could help identify preventable risk factors for hippocampal atrophy in BD. We compared brain structure using optimized voxel-based morphometry of 1.5T MRI scans in 33 BD subjects with impaired glucose metabolism (19 with insulin resistance/glucose intolerance (IR/GI), 14 with T2DM), 15 euglycemic BD participants and 11 euglycemic, nonpsychiatric controls. The group of BD patients with IR, GI or T2DM had significantly smaller hippocampal volumes than the euglycemic BD participants (corrected p=0.02) or euglycemic, nonpsychiatric controls (corrected p=0.004). Already the BD subjects with IR/GI had smaller hippocampal volumes than euglycemic BD participants (t(32)=-3.15, p=0.004). Age was significantly more negatively associated with hippocampal volumes in BD subjects with IR/GI/T2DM than in the euglycemic BD participants (F(2, 44)=9.96, p=0.0003). The gray matter reductions in dysglycemic subjects extended to the cerebral cortex, including the insula. In conclusion, this is the first study demonstrating that T2DM or even prediabetes may be risk factors for smaller hippocampal and cortical volumes in BD. Abnormal glucose metabolism may accelerate the age-related decline in hippocampal volumes in BD. These findings raise the possibility that improving diabetes care among BD subjects and intervening already at the level of prediabetes could slow brain aging in BD.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a stárnutí $x patologie $7 D000375
- 650 _2
- $a bipolární porucha $x komplikace $x metabolismus $x patologie $7 D001714
- 650 _2
- $a mozek $x patologie $7 D001921
- 650 _2
- $a průřezové studie $7 D003430
- 650 _2
- $a diabetes mellitus 2. typu $x komplikace $x patologie $7 D003924
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a porucha glukózové tolerance $7 D018149
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a počítačové zpracování obrazu $7 D007091
- 650 12
- $a inzulinová rezistence $7 D007333
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a velikost orgánu $7 D009929
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Calkin, Cynthia $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Blagdon, Ryan $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Slaney, Claire $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Uher, Rudolf $u Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
- 700 1_
- $a Alda, Martin $u 1] Department of Psychiatry, Dalhousie University, Halifax, NS, Canada [2] Prague Psychiatric Center, Department of Psychiatry and Medical Psychology, 3rd School of Medicine, Charles University, Prague, Czech Republic. $7 xx0072985
- 773 0_
- $w MED00006658 $t Neuropsychopharmacology official publication of the American College of Neuropsychopharmacology $x 1740-634X $g Roč. 39, č. 12 (2014), s. 2910-8
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25074491 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20151005 $b ABA008
- 991 __
- $a 20151014102616 $b ABA008
- 999 __
- $a ok $b bmc $g 1092810 $s 915060
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2014 $b 39 $c 12 $d 2910-8 $e 20140619 $i 1740-634X $m Neuropsychopharmacology $n Neuropsychopharmacology $x MED00006658
- LZP __
- $a Pubmed-20151005